Atrial Natriuretic Peptide Receptor 1 (Atrial Natriuretic Peptide Receptor Type A or Guanylate Cyclase A or NPR1 or EC 4.6.1.2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players
Ornithine Decarboxylase (ODC or ODC1 or EC 4.1.1.17) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players
Ubiquitin Like Modifier Activating Enzyme 1 (Ubiquitin Activating Enzyme E1 or Protein A1S9 or UBA1 or EC 6.3.2.19 or EC 6.2.1.45) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players
Squalene Monooxygenase (Squalene Epoxidase or SQLE or EC 1.14.14.17) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players
Histone Deacetylase (HDAC or EC 3.5.1.98) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players